BioLargo, Inc. | Kiromic BioPharma, Inc.

BioLargo, Inc. (OTCQB:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced the launching of a new subsidiary – BioLargo Equipment Solutions & Technologies, Inc. (BEST) – to capitalize on substantial opportunities for its technologies in the water treatment industry. BEST will enable BioLargo to represent all its water technologies under one roof providing better support for its sales and distribution network of qualified reps and channel partners. Kiromic BioPharma, Inc. (OTCQB: KRBP) reports favorable early efficacy results from the first patient enrolled in the Phase 1 Deltacel-01 clinical trial with Deltacel™ for treating stage 4 metastatic non-small cell lung cancer. For more information, please visit StockDayMedia.com Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy